AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
ANTIPSYCHOTIC DRUG REGULATION OF AMPA RECEPTOR AFFINITY STATES AND GLUR1, GLUR2 SPLICE VARIANT EXPRESSION
Authors: MCCOY L COX C RICHFIELD EK
Citation: L. Mccoy et al., ANTIPSYCHOTIC DRUG REGULATION OF AMPA RECEPTOR AFFINITY STATES AND GLUR1, GLUR2 SPLICE VARIANT EXPRESSION, Synapse, 28(3), 1998, pp. 195-207
IN-VITRO AUGMENTATION OF NMDA RECEPTOR ACTIVITY BY TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS
Authors: MCCOY L RICHFIELD EK
Citation: L. Mccoy et Ek. Richfield, IN-VITRO AUGMENTATION OF NMDA RECEPTOR ACTIVITY BY TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS, Schizophrenia research, 24(1-2), 1997, pp. 79-79
SELECTIVE LOSS OF PREPROTACHYKININ NEURONS IN A PHENOCOPY OF HUNTINGTONS-DISEASE
Authors: RICHFIELD EK VONSATTEL JP
Citation: Ek. Richfield et Jp. Vonsattel, SELECTIVE LOSS OF PREPROTACHYKININ NEURONS IN A PHENOCOPY OF HUNTINGTONS-DISEASE, Journal of neuropathology and experimental neurology, 56(5), 1997, pp. 74-74
REGIONAL DECREASES IN [H-3]AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID ([H-3]AMPA) AND 6-[H-3]CYANO-7-NITROQUINOXALINE-2,3-DIONE ([H-3]CNQX) BINDING IN RESPONSE TO CHRONIC LOW-LEVEL LEAD-EXPOSURE - REVERSAL VERSUS POTENTIATION BY CHRONIC DOPAMINE AGONIST TREATMENT
Authors: MCCOY L RICHFIELD EK CORYSLECHTA DA
Citation: L. Mccoy et al., REGIONAL DECREASES IN [H-3]AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID ([H-3]AMPA) AND 6-[H-3]CYANO-7-NITROQUINOXALINE-2,3-DIONE ([H-3]CNQX) BINDING IN RESPONSE TO CHRONIC LOW-LEVEL LEAD-EXPOSURE - REVERSAL VERSUS POTENTIATION BY CHRONIC DOPAMINE AGONIST TREATMENT, Journal of neurochemistry, 69(6), 1997, pp. 2466-2476
TIME-COURSE AND REGIONAL BASIS OF PB-INDUCED CHANGES IN MK-801 BINDING - REVERSAL BY CHRONIC TREATMENT WITH THE DOPAMINE AGONIST APOMORPHINE BUT NOT THE D-1 AGONIST SKF-82958
Authors: CORYSLECHTA DA MCCOY L RICHFIELD EK
Citation: Da. Coryslechta et al., TIME-COURSE AND REGIONAL BASIS OF PB-INDUCED CHANGES IN MK-801 BINDING - REVERSAL BY CHRONIC TREATMENT WITH THE DOPAMINE AGONIST APOMORPHINE BUT NOT THE D-1 AGONIST SKF-82958, Journal of neurochemistry, 68(5), 1997, pp. 2012-2023
ANTIPSYCHOTIC-DRUGS MODULATE AMPA RECEPTOR AFFINITY STATES
Authors: MCCOY L RICHFIELD EK
Citation: L. Mccoy et Ek. Richfield, ANTIPSYCHOTIC-DRUGS MODULATE AMPA RECEPTOR AFFINITY STATES, Biological psychiatry, 41, 1997, pp. 177-177
DENSITOMETRICAL ANALYSIS OF OPIOID RECEPTOR-LIGAND BINDING IN THE HUMAN STRIATUM .1. DISTRIBUTION OF MU-OPIOID RECEPTOR DEFINES SHELL AND CORE OF THE VENTRAL STRIATUM
Authors: VOORN P BRADY LS BERENDSE HW RICHFIELD EK
Citation: P. Voorn et al., DENSITOMETRICAL ANALYSIS OF OPIOID RECEPTOR-LIGAND BINDING IN THE HUMAN STRIATUM .1. DISTRIBUTION OF MU-OPIOID RECEPTOR DEFINES SHELL AND CORE OF THE VENTRAL STRIATUM, Neuroscience, 75(3), 1996, pp. 777-792
CHRONIC ANTIPSYCHOTIC TREATMENT ALTERS GLYCINE-STIMULATED NMDA RECEPTOR-BINDING IN RAT-BRAIN
Authors: MCCOY L RICHFIELD EK
Citation: L. Mccoy et Ek. Richfield, CHRONIC ANTIPSYCHOTIC TREATMENT ALTERS GLYCINE-STIMULATED NMDA RECEPTOR-BINDING IN RAT-BRAIN, Neuroscience letters, 213(2), 1996, pp. 137-141
PREFERENTIAL VULNERABILITY OF NUCLEUS-ACCUMBENS DOPAMINE BINDING-SITES TO LOW-LEVEL LEAD-EXPOSURE - TIME-COURSE OF EFFECTS AND INTERACTIONSWITH CHRONIC DOPAMINE AGONIST TREATMENTS
Authors: POKORA MJ RICHFIELD EK CORYSLECHTA DA
Citation: Mj. Pokora et al., PREFERENTIAL VULNERABILITY OF NUCLEUS-ACCUMBENS DOPAMINE BINDING-SITES TO LOW-LEVEL LEAD-EXPOSURE - TIME-COURSE OF EFFECTS AND INTERACTIONSWITH CHRONIC DOPAMINE AGONIST TREATMENTS, Journal of neurochemistry, 67(4), 1996, pp. 1540-1550
OPIOID RECEPTOR-LIGAND BINDING IN THE HUMAN STRIATUM .2. HETEROGENEOUS DISTRIBUTION OF KAPPA-OPIOID RECEPTOR LABELED WITH [H-3] BREMAZOCINE
Authors: VONKEMAN HE VOORN P BRADY LS BERENDSE HW RICHFIELD EK
Citation: He. Vonkeman et al., OPIOID RECEPTOR-LIGAND BINDING IN THE HUMAN STRIATUM .2. HETEROGENEOUS DISTRIBUTION OF KAPPA-OPIOID RECEPTOR LABELED WITH [H-3] BREMAZOCINE, Journal of comparative neurology, 374(2), 1996, pp. 223-229
CHRONIC TREATMENT WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS INCREASES THE AMPA-PREFERRING FORM OF AMPA RECEPTOR IN RAT-BRAIN
Authors: MCCOY L COX C RICHFIELD EK
Citation: L. Mccoy et al., CHRONIC TREATMENT WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS INCREASES THE AMPA-PREFERRING FORM OF AMPA RECEPTOR IN RAT-BRAIN, European journal of pharmacology, 318(1), 1996, pp. 41-45
WASHABLE ENDOGENOUS SUBSTANCES AND REGIONAL HETEROGENEITY IN AGONIST ENHANCED [H-3] MK-801 BINDING IN RAT-BRAIN
Authors: MCCOY L RICHFIELD EK
Citation: L. Mccoy et Ek. Richfield, WASHABLE ENDOGENOUS SUBSTANCES AND REGIONAL HETEROGENEITY IN AGONIST ENHANCED [H-3] MK-801 BINDING IN RAT-BRAIN, Brain research, 710(1-2), 1996, pp. 103-111
EFFECTS OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON AMPA SITE BINDING
Authors: MCCOY L RICHFIELD EK
Citation: L. Mccoy et Ek. Richfield, EFFECTS OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON AMPA SITE BINDING, Biological psychiatry, 39(7), 1996, pp. 295-295
IN-VITRO AGONISTS REVERSE NEUROLEPTIC-INDUCED DECLINE IN PCP SITE BINDING
Authors: MCCOY L RICHFIELD EK
Citation: L. Mccoy et Ek. Richfield, IN-VITRO AGONISTS REVERSE NEUROLEPTIC-INDUCED DECLINE IN PCP SITE BINDING, Biological psychiatry, 39(7), 1996, pp. 297-297
SUBSTANTIA-NIGRA LESIONS IN ALZHEIMER-DISEASE AND NORMAL AGING
Authors: KAZEE AM COX C RICHFIELD EK
Citation: Am. Kazee et al., SUBSTANTIA-NIGRA LESIONS IN ALZHEIMER-DISEASE AND NORMAL AGING, Alzheimer disease and associated disorders, 9(2), 1995, pp. 61-67
PREFERENTIAL LOSS OF PREPROENKEPHALIN VERSUS PREPROTACHYKININ NEURONSFROM THE STRIATUM OF HUNTINGTONS-DISEASE PATIENTS
Authors: RICHFIELD EK MAGUIREZEISS KA VONKEMAN HE VOORN P
Citation: Ek. Richfield et al., PREFERENTIAL LOSS OF PREPROENKEPHALIN VERSUS PREPROTACHYKININ NEURONSFROM THE STRIATUM OF HUNTINGTONS-DISEASE PATIENTS, Annals of neurology, 38(6), 1995, pp. 852-861
REDUCED EXPRESSION OF PREPROENKEPHALIN IN STRIATAL NEURONS FROM HUNTINGTONS-DISEASE PATIENTS
Authors: RICHFIELD EK MAGUIREZEISS KA COX C GILMORE J VOORN P
Citation: Ek. Richfield et al., REDUCED EXPRESSION OF PREPROENKEPHALIN IN STRIATAL NEURONS FROM HUNTINGTONS-DISEASE PATIENTS, Annals of neurology, 37(3), 1995, pp. 335-343
PREFERENTIAL LOSS OF PREPROENKEPHALIN VERSUS PREPROTACHYKININ STRIATAL NEURONS FROM HUNTINGTONS-DISEASE PATIENTS
Authors: RICHFIELD EK MAGUIREZEISS KA VONKEMANN HE VOORN P
Citation: Ek. Richfield et al., PREFERENTIAL LOSS OF PREPROENKEPHALIN VERSUS PREPROTACHYKININ STRIATAL NEURONS FROM HUNTINGTONS-DISEASE PATIENTS, Journal of neuropathology and experimental neurology, 54(3), 1995, pp. 458-458
DNA END LABELING (TUNEL) IN HUNTINGTONS-DISEASE AND OTHER NEUROPATHOLOGICAL CONDITIONS
Authors: THOMAS LB GATES DJ RICHFIELD EK OBRIEN TF SCHWEITZER JB STEINDLER DA
Citation: Lb. Thomas et al., DNA END LABELING (TUNEL) IN HUNTINGTONS-DISEASE AND OTHER NEUROPATHOLOGICAL CONDITIONS, Experimental neurology, 133(2), 1995, pp. 265-272
EVIDENCE FOR 2 NEUROCHEMICAL DIVISIONS IN THE HUMAN NUCLEUS-ACCUMBENS
Authors: VOORN P BRADY LS SCHOTTE A BERENDSE HW RICHFIELD EK
Citation: P. Voorn et al., EVIDENCE FOR 2 NEUROCHEMICAL DIVISIONS IN THE HUMAN NUCLEUS-ACCUMBENS, European journal of neuroscience, 6(12), 1994, pp. 1913-1916
SELECTIVE VULNERABILITY IN HUNTINGTONS-DISEASE - PREFERENTIAL LOSS OFCANNABINOID RECEPTORS IN LATERAL GLOBUS-PALLIDUS
Authors: RICHFIELD EK HERKENHAM M
Citation: Ek. Richfield et M. Herkenham, SELECTIVE VULNERABILITY IN HUNTINGTONS-DISEASE - PREFERENTIAL LOSS OFCANNABINOID RECEPTORS IN LATERAL GLOBUS-PALLIDUS, Annals of neurology, 36(4), 1994, pp. 577-584
REDUCTION IN PREPROENKEPHALIN MESSENGER-RNA EXPRESSION IN STRIATAL NEURONS FROM INDIVIDUALS WITH HUNTINGTONS-DISEASE
Authors: RICHFIELD EK MAGUIRE K GILMORE J COX C VOORN P
Citation: Ek. Richfield et al., REDUCTION IN PREPROENKEPHALIN MESSENGER-RNA EXPRESSION IN STRIATAL NEURONS FROM INDIVIDUALS WITH HUNTINGTONS-DISEASE, Annals of neurology, 36(2), 1994, pp. 281-281
THE RELATIONSHIP OF ESSENTIAL TREMOR TO OTHER MOVEMENT-DISORDERS - REPORT ON 678 PATIENTS
Authors: KOLLER WC BUSENBARK K MINER K ADAIR JC AIGNER BR ALBIN RI ALEXANDER DN ANTO CM BENDER SE BERG MJ BERGIA BM BLALOCK E BURNS RS COUCH JR CRISOSTOMO EA DAVIS LS DAVIS TL DIETRICH DW DIMITSOPULOS TM DOORENBOS D ELLIS JR ERTAG WD FACTOR SA FEIGIN AS FREY KA GADDIS KA GIBSON GL GOLDEN RE GORDON MF GREENAMYRE JT GRIFFITH PA GROTTA JC HAUSER RA HEIDEBRINK JL HIGGINS DC HILL SA HILL TA HUBBLE JP HUTTON JT JOHNSTON W KIEBURTZ KD KURLAN RM LABUNETZ WH LIEBERMAN AN MAJUMDAR L MARAGOS WF MCCLOSKEY T MCPHERSON SL MILLER BR NINO HE OBRIEN CF ONEILL A OOMMEN KJ OSBORN MA PAHWA R PAULSON GW PODSKALNY GD POOLE RM PROTASS LM PUGLIA JF RICHFIELD EK RILEY DE SADEGHI H SCHWARTZ H SERANO RD SHANNON KM SHOULSON L SHULMAN LM SHULTS CW SILVERSTEIN PM SLEVIN JT SNYDER RA SOMERS AB STACY M SULLIVAN LP VANHORN G WEINER WJ WEISS HD WILLNER J WILLIAMS MH WONG GF ZWIEBEL F
Citation: Wc. Koller et al., THE RELATIONSHIP OF ESSENTIAL TREMOR TO OTHER MOVEMENT-DISORDERS - REPORT ON 678 PATIENTS, Annals of neurology, 35(6), 1994, pp. 717-723
DISTRIBUTIONS OF GABA(A), GABA(B), AND BENZODIAZEPINE RECEPTORS IN THE FOREBRAIN AND MIDBRAIN OF PIGEONS
Authors: VEENMAN CL ALBIN RL RICHFIELD EK REINER A
Citation: Cl. Veenman et al., DISTRIBUTIONS OF GABA(A), GABA(B), AND BENZODIAZEPINE RECEPTORS IN THE FOREBRAIN AND MIDBRAIN OF PIGEONS, Journal of comparative neurology, 344(2), 1994, pp. 161-189
HYPERACTIVITY AND REDUCTION IN SUSTAINED BEHAVIOR FOLLOWING PERINATALHYPOXIA
Authors: MCCOY L SCHWARZKOPF SB RICHFIELD EK
Citation: L. Mccoy et al., HYPERACTIVITY AND REDUCTION IN SUSTAINED BEHAVIOR FOLLOWING PERINATALHYPOXIA, Biological psychiatry, 35(9), 1994, pp. 724-725
Risultati: 1-25 | 26-27